SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001171843-10-002609
Filing Date
2010-12-14
Accepted
2010-12-14 06:00:34
Documents
23
Period of Report
2010-12-13
Items
Item 7.01: Regulation FD Disclosure
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K f8k_121410.htm 8-K 24269
2 EXHIBIT 99.1 exh_991.htm EX-99 87752
3 EXHIBIT 99.2 exh_992.htm EX-99 23178
4 bl1.gif GRAPHIC 167
5 bl2.gif GRAPHIC 82
6 exh_9911.jpg GRAPHIC 25735
7 exh_9912.jpg GRAPHIC 32787
8 exh_9913.jpg GRAPHIC 44783
9 exh_9914.jpg GRAPHIC 24825
10 exh_9915.jpg GRAPHIC 15145
11 exh_9916.jpg GRAPHIC 15145
12 exh_9917.jpg GRAPHIC 15145
13 exh_9918.jpg GRAPHIC 15145
14 exh_9919.jpg GRAPHIC 15145
15 exh_99110.jpg GRAPHIC 34822
16 exh_99111.jpg GRAPHIC 37050
17 exh_99112.jpg GRAPHIC 15145
18 exh_99113.jpg GRAPHIC 15145
19 exh_99114.jpg GRAPHIC 15145
20 exh_99115.jpg GRAPHIC 15145
21 exh_99116.jpg GRAPHIC 25735
22 exh_99117.jpg GRAPHIC 25735
23 exh_99118.jpg GRAPHIC 35465
  Complete submission text file 0001171843-10-002609.txt   722730
Mailing Address 1275 WEST WASHINGTON STREET SUITE 101 TEMPE AZ 85281
Business Address 1275 WEST WASHINGTON STREET SUITE 101 TEMPE AZ 85281 6022865520
Capstone Therapeutics Corp. (Filer) CIK: 0000887151 (see all company filings)

IRS No.: 860585310 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-33560 | Film No.: 101249353
SIC: 2834 Pharmaceutical Preparations